The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Sanofi Pasteur’s Dengue Vaccine Shows Proof Of Efficacy: Study
The results of the world’s first dengue vaccine efficacy study confirm the safety of Sanofi Pasteur’s dengue vaccine against 3 out of 4 dengue virus serotypes.
Sanofi’s Dengue Vaccine Promising But Offers Incomplete Protection
A late-stage clinical trial has shown that Sanofi's dengue vaccine reduces dengue hemorrhagic fever by 89 percent but does not protect against serotype 2.
GHIT Awards Seven New Grants Amounting To US$15.3 Million
Research in the neglected tropical diseases of dengue, malaria and Chagas disease receive a US$15.3 million boost in funding from GHIT.
Phase 1/2 Results For Takeda’s Norovirus Vaccine
Takeda has announced the results of a Phase 1/2 study of its norovirus vaccine candidate which was found to be well tolerated.
Rotaviruses Use Blood Group Antigens
Researchers have shown that rotaviruses bind to Type A antigens, using them to infect cells.
China’s Future TB Rates Likely To Be Driven By The Elderly
TB vaccines that work well in the elderly could be key to stemming the disease in China, scientists say.
Hilleman & Gotovax Collaborate On Cholera Vaccine
The oral cholera vaccine currently in preclinical development will be cheaper, easy to administer and cross-protective for different types of bacteria.
Bridging The Gaps In Asian Vaccine Development
Countries in Asia hope that home-grown, locally manufactured vaccines will meet domestic needs, but considerable challenges stand in the way, say experts and industry leaders at the World Vaccine Congress Asia.
Takeda Invests In Vaccine Safe Co.
Alfresa's Vaccine Scheduling System helps parents keep track of their children's increasingly complex vaccination schedules.